Concomitant Analysis of EZH2 and ASXL1 Mutations In Myelofibrosis, Chronic Myelomonocytic Leukemia and Blast-Phase Myeloproliferative Neoplasms

被引：0
|
作者：
Abdel-Wahab, Omar
Pardanani, Animesh
Patel, Jay
Lasho, Terra [2 ]
Heguy, Adriana
Levine, Ross [1 ]
Tefferi, Ayalew
机构：
[1] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
[2] Mayo Clin, Div Hematol, Dept Med, Rochester, MN USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1266 / 1266
页数：1
相关论文
共 50 条
  • [1] Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
    O Abdel-Wahab
    A Pardanani
    J Patel
    M Wadleigh
    T Lasho
    A Heguy
    M Beran
    D G Gilliland
    R L Levine
    A Tefferi
    Leukemia, 2011, 25 : 1200 - 1202
  • [2] Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
    Abdel-Wahab, O.
    Pardanani, A.
    Patel, J.
    Wadleigh, M.
    Lasho, T.
    Heguy, A.
    Beran, M.
    Gilliland, D. G.
    Levine, R. L.
    Tefferi, A.
    LEUKEMIA, 2011, 25 (07) : 1200 - 1202
  • [3] EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
    Mrinal M. Patnaik
    Rangit Vallapureddy
    Terra L. Lasho
    Katherine P. Hoversten
    Christy M. Finke
    Rhett Ketterling
    Curtis Hanson
    Naseema Gangat
    Ayalew Tefferi
    Blood Cancer Journal, 8
  • [4] EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
    Patnaik, Mrinal M.
    Vallapureddy, Rangit
    Lasho, Terra L.
    Hoversten, Katherine P.
    Finke, Christy M.
    Ketterling, Rhett
    Hanson, Curtis
    Gangat, Naseema
    Tefferi, Ayalew
    BLOOD CANCER JOURNAL, 2018, 8
  • [5] Prognostic Impact of EZH2 and ASXL1 Mutation in Myelofibrosis
    Guglielmelli, Paola
    Biamonte, Flavia
    Score, Johannah
    Hidalgo-Curtis, Claire
    Cervantes, Francisco
    Maffioli, Margherita
    Fanelli, Tiziana
    Ernst, Thomas
    Winkelman, Nils
    Jones, Amy V.
    Zoi, Katerina
    Reiter, Andreas
    Duncombe, Andrew
    Villani, Laura
    Paoli, Chiara
    Bosi, Alberto
    Barosi, Giovanni
    Cross, Nicholas C. P.
    Vannucchi, Alessandro M.
    BLOOD, 2011, 118 (21) : 1212 - 1212
  • [6] Co-existing squamous cell carcinoma and chronic myelomonocytic leukemia with ASXL1 and EZH2 gene mutations: A case report
    Deng, Lai-Jun
    Dong, Yang
    Li, Mi-Mi
    Sun, Chang-Gang
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (15) : 3643 - 3650
  • [7] Co-existing squamous cell carcinoma and chronic myelomonocytic leukemia with ASXL1 and EZH2 gene mutations: A case report
    Lai-Jun Deng
    Yang Dong
    Mi-Mi Li
    Chang-Gang Sun
    World Journal of Clinical Cases, 2023, (15) : 3643 - 3650
  • [8] PROGNOSTIC VALUE OF MUTATIONS IN ASXL1 IN CHRONIC MYELOMONOCYTIC LEUKEMIA
    Almorox Rebeca, Bailen
    Gonzalez Julia, Suarez
    Carolina, Martinez-Laperche
    Noemi, Fernandez-Escalada
    Maria, Chicano-Lavilla
    Diego, Carbonell
    Patricia, Font
    Santiago, Osorio
    Jose Lui, Diez-Martin
    Ismael, Buno
    HAEMATOLOGICA, 2016, 101 : 153 - 154
  • [9] TET2 and ASXL1 Mutations in Leukemic Transformation of Chronic Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Manshouri, Taghi
    Patel, Jay
    Harris, Kelly
    Yao, Jin Juan
    Hedvat, Cyrus V.
    Heguy, Adriana
    Bueso-Ramos, Carlos
    Kantarjian, Hagop M.
    Levine, Ross L.
    Verstovsek, Srdan
    BLOOD, 2009, 114 (22) : 1130 - 1131
  • [10] Mutations of EZH2 In Myeloproliferative Neoplasms with Myelofibrosis: Correlation with Molecular and Clinical Data
    Stegelmann, Frank
    Schlenk, Richard F.
    Griesshammer, Martin
    Paschka, Peter
    Blersch, Carmen
    Kuhn, Susanne
    Schauer, Stefanie
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2010, 116 (21) : 1674 - 1674
12345